The CLU gene helps your cells handle stress, clear away damaged proteins, and support tissue repair. If it does not work as expected, cells may be less able to manage injury and protein buildup, which can affect how well tissues stay healthy over time. Some variants in the CLU gene are linked to a higher chance of late onset Alzheimer disease, but they influence risk rather than determine whether a person will develop it.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some provide the directions for building proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they may influence how you respond to food, stress, or medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
CLUGene function
What if the gene works
The CLU gene helps make clusterin, a protein that protects cells under stress. It helps keep damaged proteins from clumping so they can be cleared, and supports waste removal and immune balance in tissues, including the brain.
Risk
What if the gene does not work
Some variants in the CLU gene have little effect, while more disruptive variants can lower or alter clusterin activity. This may weaken protein folding support, lipid transport, and cleanup of cell debris, changing how cells handle stress and inflammation.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic or loss-of-function variants in the CLU gene, so drug choices are usually based on the person’s diagnosed condition rather than the variant itself. The CLU gene is being studied as a biomarker and possible drug target in Alzheimer disease and in some cancers.
Gene function
What if the gene works
Your cells and body fluids rely on the CLU gene to keep proteins stable, move fats, and support normal cleanup. It makes clusterin, a protein found in many tissues, blood, and other fluids. This helps explain what the CLU gene does in the body from day to day.
Clusterin binds proteins that have lost their usual shape outside cells. This helps stop them from sticking together and makes them easier for the body to clear.
Clusterin can attach to cell debris and protein bundles marked for removal. This supports routine housekeeping in tissues and body fluids after normal daily stress.
Clusterin travels with fat carrying particles in the blood and helps move cholesterol and other fats between places in the body. This supports cell membranes, which are the thin outer layers around cells.
Clusterin can calm parts of the complement system, a protein network that helps with immune cleanup. This helps keep normal defense activity more controlled around healthy tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CLU gene can change how the clusterin protein folds, is processed, or is released from cells, which is central to how CLU gene variants affect protein function. Some missense variants cause milder shifts in protein stability or binding, while more disruptive variants can sharply reduce protein production or secretion. When the change is larger, the protein may be less able to interact with other proteins and cell membranes.
How variants are linked to conditions
Among CLU gene variants linked to conditions, the clearest and most widely accepted association is with late onset Alzheimer disease. Common variants in the CLU gene are associated with a modest change in the chance of developing Alzheimer disease, especially in population studies, but they do not confirm a diagnosis. For most people, these variants are one small part of overall dementia risk alongside age, family history, and other health factors.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a part. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Some changes in the CLU gene are linked with a small shift in the chance of developing late-onset Alzheimer’s disease, but they do not determine what will happen. Age, family history, and overall brain and heart health also play a part, including blood pressure, diabetes, smoking, exercise, and sleep.
Inheritance of CLU variants
There is not yet a broadly confirmed Mendelian pattern for how CLU gene variants are inherited in relation to a specific CLU-related genetic condition. Most often, CLU is discussed as a gene that may influence risk, rather than as one that follows a clear autosomal dominant or autosomal recessive pattern. For people looking into how CLU gene variants are inherited, CLU is located on chromosome 8, which is an autosome. That means you inherit one copy of the CLU gene from each parent.
What does my CLU result mean for my family?
There is not yet a broadly confirmed pattern showing that a CLU result by itself explains a specific inherited condition in families. Some CLU changes are being studied for their possible role in health, but what they mean for relatives is not always clear and depends on the exact result and the health concern being evaluated.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CLU gene variants uses a blood or saliva sample to read your DNA and look for changes in the CLU gene. It can confirm whether a specific variant is present, but for common conditions such as Alzheimer disease, CLU results usually add risk information rather than a diagnosis.
When should I consider getting a genetic test?
There is not yet a broadly established, CLU-specific medical reason to get genetic testing. If memory problems or dementia run strongly in your family, testing decisions are best made with a doctor or genetic counselor, who can decide whether broader genetic testing may be useful.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies based on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation can affect a person’s response to medication. It focuses on relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the CLU gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices or predicting medicine side effects in routine care. If you have concerns about how a treatment is working, notice new side effects, or want help reviewing your medicines, talk with your doctor.
History
The CLU gene entered research under several different names, reflecting how often it was rediscovered in different tissues and diseases. It was first characterized in the 1980s, when scientists studying reproductive tissues described a protein linked to cell clustering and gave it the name clusterin. Early reports also referred to it as APOJ and other names, and Scientific classifications changed as researchers learned more about the gene. During the 1990s and 2000s, CLU drew wider interest in cancer, aging, and neurodegenerative research. A major turning point came in 2009, when large genetic studies linked common variants near the CLU gene to Alzheimer disease risk. That finding made CLU one of the most discussed genes in Alzheimer genetics research.